Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Veracyte Inc (VCYT)

Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Veracyte to Participate in Upcoming Investor Conferences Business Wire - Thu Nov 6, 7:30AM CST

Veracyte, Inc. (Nasdaq: VCYT) a leading cancer diagnostics company, announced today it will participate in the following investor conferences. ...

VCYT : 43.70 (+2.01%)
Veracyte: Q3 Earnings Snapshot AP - Tue Nov 4, 4:31PM CST

Veracyte: Q3 Earnings Snapshot

VCYT : 43.70 (+2.01%)
Veracyte Announces Third Quarter 2025 Financial Results Business Wire - Tue Nov 4, 3:05PM CST

Grew total revenue to $131.9 million and testing revenue to $127.8 million, representing increases of 14% and 17% year-over-year, respectively Conference call and webcast...

VCYT : 43.70 (+2.01%)
Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing Business Wire - Mon Nov 3, 3:15PM CST

Landmark studies leverage Afirma GRID whole transcriptome-derived data to identify molecular classifiers and signatures differentiating thyroid cancer risk groups

VCYT : 43.70 (+2.01%)
Veracyte to Release Third Quarter 2025 Financial Results on November 4, 2025 Business Wire - Wed Oct 15, 4:31PM CDT

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the third quarter of 2025 after the close of market on Tuesday, November...

VCYT : 43.70 (+2.01%)
Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Business Wire - Sun Sep 28, 3:00PM CDT

Findings from the first prospective validation trial for biomarker presented at ASTRO 2025

VCYT : 43.70 (+2.01%)
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus Newswire.ca - Thu Sep 25, 8:15AM CDT

/CNW/ -- America's aging demographics are creating unprecedented demand for precision healthcare solutions, with population projections showing nearly one in...

VCYT : 43.70 (+2.01%)
HUM : 274.91 (+2.41%)
QURE : 20.49 (+5.02%)
AVAI : 0.3155 (-4.36%)
EDIT : 2.44 (-3.56%)
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus PR Newswire - Thu Sep 25, 8:15AM CDT

USA News Group News Commentary

VCYT : 43.70 (+2.01%)
QURE : 20.49 (+5.02%)
HUM : 274.91 (+2.41%)
AVAI : 0.3155 (-4.36%)
EDIT : 2.44 (-3.56%)
Veracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025 Business Wire - Wed Sep 24, 8:00AM CDT

Findings are among nine Decipher-focused abstracts being presented at annual conference

VCYT : 43.70 (+2.01%)
Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting Business Wire - Tue Sep 9, 8:00AM CDT

Studies leverage company’s Afirma Genomic Resource for Intelligent Discovery (GRID), world’s largest molecular database for thyroid nodules

VCYT : 43.70 (+2.01%)

Barchart Exclusives

The QQQ Is at Risk of a Christmas Crash, So Pay Attention to Bond Yields Right Now Barchart - 27 minutes ago
It’s past time that stock market participants started paying attention to bonds. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot